Small Molecules

03 Apr 2018 Allergan and Richter Announce Positive Topline Results from Third of Three Pivotal Trials of Cariprazine in Bipolar I Depression
03 Apr 2018 Motif Bio Initiates NDA Rolling Submission for Iclaprim and Provides Business Update
03 Apr 2018 Status update of the Phase III ARAMIS clinical trial with darolutamide in patients with non-metastatic castration-resistant prostate cancer
03 Apr 2018 Rigel Announces Topline Data from Proof-of-Concept Phase 2 Study of Fostamatinib in IgA Nephropathy
03 Apr 2018 The European Medicines Agency accepts regulatory submission for Lynparza in BRCA-mutated HER2-negative metastatic breast cancer
03 Apr 2018 Alkermes Receives Refusal to File Letter From FDA for ALKS 5461
02 Apr 2018 Sunovion Submits New Drug Application to the FDA for Apomorphine Sublingual Film (APL-130277) for the Treatment of OFF Episodes Associated with Parkinson’s Disease
02 Apr 2018 MyoKardia Begins Dosing in Phase 2 MAVERICK-HCM Clinical Trial of Mavacamten in Symptomatic Non-obstructive Hypertrophic Cardiomyopathy Patients
02 Apr 2018 Eisai Submits Supplemental New Drug Application (sNDA) to FDA for FYCOMPA® (perampanel) Pediatric Indications
30 Mar 2018 Pfizer Announces Positive Topline Results From Phase 3 ATTR-ACT Study Of Tafamidis In Patients With Transthyretin Cardiomyopathy
29 Mar 2018 RXC004 Clinical Trial Update
29 Mar 2018 Commencement Of Phase II Clinical Study Of GDC-0084
29 Mar 2018 EMA to review sotagliflozin as potential treatment for type 1 diabetes
29 Mar 2018 Insmed Submits New Drug Application to FDA for ALIS in NTM Lung Disease Caused by MAC
29 Mar 2018 Catalyst Pharmaceuticals Announces Submission of New Drug Application for Firdapse® for Treatment of Lambert-Eaton Myasthenic Syndrome
28 Mar 2018 Combioxin Announces Completion of CAL02 FIM Trial in Patients with Severe Pneumococcal Pneumonia
28 Mar 2018 Edge Therapeutics Provides Update following Interim Analysis of Phase 3 NEWTON 2 Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
28 Mar 2018 Urovant Sciences Initiates Phase 3 Clinical Program for Vibegron in Patients with Overactive Bladder
28 Mar 2018 Esperion Announces Positive Top-Line Results from Phase 2 Study of Bempedoic Acid Added-On to a PCSK9 Inhibitor in Patients with Hypercholesterolemia
26 Mar 2018 Flex Pharma Reports Positive Topline Data from Exploratory Phase 2 Trial of FLX-787 in Multiple Sclerosis
26 Mar 2018 Biohaven Announces Successful Achievement of Both Co-Primary Regulatory Endpoints in Two Pivotal Phase 3 Trials of Rimegepant an Oral CGRP Receptor Antagonist for the Acute Treatment of Migraine
26 Mar 2018 Allecra Therapeutics Announces Positive Top-Line Results from Phase 2 CACTUS Study of its Lead Candidate, AAI101, in Combination with Cefepime to Treat Complicated Urinary Tract Infections (cUTI)
26 Mar 2018 Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554 for Maintenance Treatment of COPD
26 Mar 2018 Lexicon Pharmaceuticals Announces Regulatory Submissions for Sotagliflozin to Treat Adults With Type 1 Diabetes
26 Mar 2018 Bayer Announces Completion of Rolling Submission of New Drug Application in the U.S. for Larotrectinib for the Treatment of TRK Fusion Cancer

La Merie Biologics

FREE Weekly News Bulletin

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing